Mayo Clinic's Center for Clinical and Translational Science (CCaTS) offers resources to ... also are available periodically through CCaTS Drug Discovery and Development. If you have a project you are ...

AI models are able to design molecules that don’t even exist in nature. Some have proven effective as snake antivenom.

A global team has made a significant advance in understanding how bacterial plasmids contribute to antibiotic resistance.

Konstanz biologist Patrick Müller receives a Proof of Concept Grant from the European Research Council for his project "EmbryoNet-AI". Its goal is the further development of an AI-supported platform ...

The CEO of Google Mind has suggested clinical trials of the first drugs designed with the help of AI could begin this year.

A new study from the Kowalinski group at EMBL Grenoble characterized the structure of an important trypanosomal protein ...

From accelerating drug development and clinical trials to supercharging collaboration, machine learning-enhanced healthcare ...

The proof-of-concept demonstrates the power of pairing AI with lab orchestration solutions to automate molecular screening ...

Targeted therapies for high-risk leukemia in children have yet to be developed, but scientists at Université de Montréal and ...

Collaborative project with world leader in AI computing demonstrates Artificial workflows and model integration for self-driving generative virtual screening in drug discovery. Company also announces ...

The Master of Science degree program in Drug Discovery & Development (DDD ... and pharmacogenomics. Working in project teams, students get practical experience implementing strategies. Both full-time ...